K243038

Substantially Equivalent

Salix Central

Applicant: Artrya Limited
Product code: QIH
Advisory panel: Radiology
Date received: 2024-09-27
Decision date: 2025-03-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Perth, AU

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.